Molecular Cancer Therapeutics Chemical and Biological Aspects of Inflammation and Cancer Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Molecular Cancer Therapeutics 7, 2142-2151, July 1, 2008. doi: 10.1158/1535-7163.MCT-08-0005
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Rajasekaran, S. A.
Right arrow Articles by Rajasekaran, A. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajasekaran, S. A.
Right arrow Articles by Rajasekaran, A. K.

Research Articles: Therapeutics, Targets, and Development

Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability

Sigrid A. Rajasekaran1, Jason J. Christiansen2, Ingrid Schmid3, Eri Oshima2, Kathleen Sakamoto2,3, Jasminder Weinstein4, Nagesh P. Rao2 and Ayyappan K. Rajasekaran1

1 Nemours Center for Childhood Cancer Research, Alfred I. DuPont Hospital for Children, Wilmington, Delaware; Departments of 2 Pathology and Laboratory Medicine and 3 Hematology/Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California; and 4 Amgen, Inc., Thousand Oaks, California

Requests for reprints: Ayyappan K. Rajasekaran, Nemours Center for Childhood Cancer Research, Alfred I. DuPont Hospital for Children, Rockland Center I, 1701 Rockland Road, Wilmington, DE 19803. Phone: 302-651-6593; Fax: 302-651-4827. E-mail: araj{at}medsci.udel.edu

Abstract

Prostate-specific membrane antigen (PSMA) is a transmembrane protein highly expressed in advanced and metastatic prostate cancers. The pathologic consequence of elevated PSMA expression in not known. Here, we report that PSMA is localized to a membrane compartment in the vicinity of mitotic spindle poles and associates with the anaphase-promoting complex (APC). PSMA-expressing cells prematurely degrade cyclin B and exit mitosis due to increased APC activity and incomplete inactivation of APC by the spindle assembly checkpoint. Further, expression of PSMA in a karyotypically stable cell line induces aneuploidy. Thus, these findings provide the first evidence that PSMA has a causal role in the induction of aneuploidy and might play an etiologic role in the progression of prostate cancer. [Mol Cancer Ther 2008;7(7):2142–51]


Footnotes

Grant support: Department of Defense grant W81XWH-04-1-0113 and NIH grant DK56216.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Note: S.A. Rajasekaran and J.J. Christiansen contributed equally to this work.

5 S.A. Rajasekaran et al., unpublished data.

Received 1/ 4/08; revised 3/ 6/08; accepted 3/ 8/08.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.